We are live on ! Find out more
INBP

INTEGRATED BIOPHARMA INC.
INBP

Delisted

INBP was delisted on the 26th of February, 2009.

Back to rankings

1 hedge funds and large institutions have $4.9K invested in INTEGRATED BIOPHARMA INC. in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

12% less capital invested

Capital invested by funds: $5.6K → $4.9K (-$698)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MSAM
1
Moloney Securities Asset Management
Missouri
$4.9K – – –

INBP Hedge Fund Activity: Q4 2023 in Review

1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in INTEGRATED BIOPHARMA INC. (INBP) for Q4 2023, worth a combined $4.9K — down 12% from $5.6K a quarter earlier.

Fund positioning in INBP was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held INTEGRATED BIOPHARMA INC. (INBP) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $4.9K of INTEGRATED BIOPHARMA INC. stock for Q4 2023, down 12% quarter-over-quarter.
  • 0 funds opened new INTEGRATED BIOPHARMA INC. positions in Q4 2023 and 0 closed out.

Based on aggregated 13F filings for Q4 2023.